Pharmacological repositioning of Achyranthes aspera as an antidepressant using pharmacoinformatic tools PASS and PharmaExpert: a case study with wet lab validationFootnote^$

^$Presented at the 9th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources, CMTPI-2017, 27–30 October 2017, Goa, India.

References

• H. Lavretsky, Complementary and alternative medicine use for treatment and prevention of late-life mood and cognitive disorders, Aging Health 5 (2009), pp. 61–78.
   PubMedGoogle Scholar
• N.A. Qureshi and A.M. Al-Bedah, Mood disorders and complementary and alternative medicine: A literature review, Neuropsychiatr. Dis. Treat. 9 (2013), pp. 639–658.
   PubMed Web of Science ®Google Scholar
• A. Ganesan, The impact of natural products upon modern drug discovery, Curr. Opin. Chem. Biol. 12 (2008), pp. 306–317.
   PubMed Web of Science ®Google Scholar
• A. Lagunin, D.S. Druzhilovsky, A.V. Rudik, D.A. Filimonov, D. Gawande, K. Suresh, R. Goel, and V.V. Poroikov, Capacities of computer evaluation of hidden potential of phytochemicals of medicinal plants of the traditional Indian Ayurvedic medicine, Biomed. Chem. 10 (2016), pp. 43–54.
   Google Scholar
• A.A. Lagunin, R.K. Goel, D.Y. Gawande, P. Pahwa, T.A. Gloriozova, A.V. Dmitriev, S.M. Ivanov, A.V. Rudik, V.I. Konova, P.V. Pogodin, D.S. Druzhilovsky, and V.V. Poroikov, Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: A critical review, Nat. Prod. Rep. 31 (2014), pp. 1585–1611.
   PubMed Web of Science ®Google Scholar
• D. Singh, D.Y. Gawande, T. Singh, V. Poroikov, and R.K. Goel, Revealing pharmacodynamics of medicinal plants using in silico approach: A case study with wet lab validation, Comput. Biol. Med. 47 (2014), pp. 1–6.
   PubMed Web of Science ®Google Scholar
• R.K. Goel, D. Gawande, A. Lagunin, P. Randhawa, A. Mishra, and V. Poroikov, Revealing medicinal plants that are useful for the comprehensive management of epilepsy and associated comorbidities through in silico mining of their phytochemical diversity, Planta Med. 81 (2015), pp. 495–506.
   PubMed Web of Science ®Google Scholar
• K.M. Choudhary, A. Mishra, V.V. Poroikov, and R.K. Goel, Ameliorative effect of curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice, Eur. J. Pharmacol. 704 (2013), pp. 33–40.
   PubMed Web of Science ®Google Scholar
• D.Y. Gawande and R.K. Goel, Pharmacological validation of in silico guided novel nootropic potential of Achyranthes aspera L, J. Ethnopharmacol. 175 (2015), pp. 324–334.
   PubMed Web of Science ®Google Scholar
• P. Pahwa and R.K. Goel, Asparagus adscendens root extract enhances cognition and protects against scopolamine induced amnesia: An in-silico and in-vivo studies, Chem. Biol. Interac. 260 (2016), pp. 208–218.
   PubMed Web of Science ®Google Scholar
• S. Srivastav, P. Singh, G. Mishra, K.K. Jha, and R.L. Khosa, Achyranthes aspera-an important medicinal plant: A review, J. Nat. Prod. Plant Resour. 1 (2011), pp. 1–14.
   Google Scholar
• A. Lagunin, D. Filimonov, and V. Poroikov, Multi-targeted natural products evaluation based on biological activity prediction with PASS, Curr. Pharm. Des. 16 (2010), pp. 1703–1717.
   PubMed Web of Science ®Google Scholar
• V. Poroikov, A. Lagunin, and D. Filimonov, PharmaExpert: Diseases, targets and ligands – three in one, in QSAR and Molecular Modelling in Rational Design of Bioactive Molecules, E.A. Sener and I. Yalcin, eds., CADD & D Society, Ankara, Turkey, 2005, pp. 514–515.
   Google Scholar
• A. Snehunsu, C. Ghosal, M. Kandwal, P.K. Yadav, B.S. Nayak, K.R. Rao, S.U. Kamath, P. Sahoo, K.K. Srinivasan, S.N. Naduvil, S. Kumar, and A. Joseph, 1-Triacontanol cerotate; isolated from Marsilea quadrifolia Linn. ameliorates reactive oxidative damage in the frontal cortex and hippocampus of chronic epileptic rats, J. Ethnopharmacol. 172 (2015), pp. 80–84.
   PubMed Web of Science ®Google Scholar
• OECD, Guideline for testing of chemicals, guidance no. 423. Acute Oral Toxicity: Acute Toxic Class Method, OECD, Paris, France, 2001.
   Google Scholar
• R.D. Porsolt, A. Bertin, and M. Jalfre, Behavioral despair in mice: A primary screening test for antidepressants, Arch. Int. Pharmacodyn. 229 (1977), pp. 327–336.
   PubMedGoogle Scholar
• L. Steru, R. Chermat, B. Thierry, and P. Simon, The tail suspension test: A new method for screening antidepressants in mice, Psychopharmacology 85 (1985), pp. 367–370.
   PubMed Web of Science ®Google Scholar
• A. Zapata, V.I. Chefer, S. Parrot, and L. Denoroy, Detection and quantification of neurotransmitters in dialysates, Curr. Protoc. Neurosci. 7 (2009), pp. 1–30.
   PubMedGoogle Scholar
• M. Ali, Chemical investigation of Achyranthes aspera Linn, Orient. J. Chem. 9 (1993), pp. 84–85.
   Google Scholar
• T.J. Connor, P. Kelliher, Y. Shen, A. Harkin, J.P. Kelly, and B.E. Leonard, Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test, Pharmacol. Biochem. Behav. 65 (2000), pp. 591–597.
   PubMed Web of Science ®Google Scholar
• M.J. Detke, M. Rickels, and I. Lucki, Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants, Psychopharmacology (Berl.) 121 (1995), pp. 66–72.
   PubMed Web of Science ®Google Scholar
• J.J. Schildkraut, E.K. Gordon, and J. Durell, Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine, J. Psychiatr. Res. 3 (1965), pp. 213–228.
   PubMed Web of Science ®Google Scholar
• A. Coppen, The biochemistry of affective disorders, Br. J. Psychiatry 113 (1967), pp. 1237–1264.
   PubMed Web of Science ®Google Scholar
• A. Randrup, J. Munkvad, R. Fog, I. Gerlach, L. Molander, B. Kjellberg, and J. Scheel-Kriiger, Mania, depression, and brain dopamine, in Current Developments in Psychopharmacology 2, W.B. Essman and L. Valzelli, eds., Spectrum Publications, New York, 1975, pp. 206–248.
   Google Scholar
• A.S. Elhwuegi, Central monoamines and their role in major depression, Prog. Neuropsychopharmacol. Biol. Psychiatry 28 (2004), pp. 435–451.
   PubMed Web of Science ®Google Scholar
• B. Haenisch and H. Bönisch, Depression and antidepressants: Insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters, Pharmacol. Ther. 129 (2011), pp. 352–368.
   PubMed Web of Science ®Google Scholar
• M. Páez-Pereda, New drug targets in the signaling pathways activated by antidepressants, Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005), pp. 1010–1016.
   PubMed Web of Science ®Google Scholar
• Z. Chen and P. Skolnick, Triple uptake inhibitors: Therapeutic potential in depression and beyond, Expert Opin. Investig. Drugs 16 (2007), pp. 1365–1377.
   PubMed Web of Science ®Google Scholar